Cite
The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling
MLA
Ailin Luo, et al. “The Soluble Epoxide Hydrolase Inhibitor TPPU Improves Comorbidity of Chronic Pain and Depression via the AHR and TSPO Signaling.” Journal of Translational Medicine, vol. 21, Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88f56b9cbf9ded1c83819ee06954448d&authtype=sso&custid=ns315887.
APA
Ailin Luo, Zifeng Wu, Shan Li, Cindy B. McReynolds, Di Wang, Hanyu Liu, Chaoli Huang, Teng He, Xinying Zhang, Yuanyuan Wang, Cunming Liu, Bruce D. Hammock, Kenji Hashimoto, & Chun Yang. (2023). The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling. Journal of Translational Medicine, 21.
Chicago
Ailin Luo, Zifeng Wu, Shan Li, Cindy B. McReynolds, Di Wang, Hanyu Liu, Chaoli Huang, et al. 2023. “The Soluble Epoxide Hydrolase Inhibitor TPPU Improves Comorbidity of Chronic Pain and Depression via the AHR and TSPO Signaling.” Journal of Translational Medicine 21 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88f56b9cbf9ded1c83819ee06954448d&authtype=sso&custid=ns315887.